Is standardised ¹⁸F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Fluorodeoxyglucose F 18 100%
• Neoplasm 80%
• Distant Metastasis 80%
• Overall Survival 40%
• Prognostic Factor 40%
• Polyethylene Terephthalate 40%
• Recurrent Disease 20%
• Cancer Staging 20%
• Tumor Cell 20%
• Neoadjuvant Therapy 20%
• Standardized Uptake Value 20%
• Tumor Histology 20%
• Disease Free Survival 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Neoplasm 100%
• Fluorodeoxyglucose F 18 100%
• Non Small Cell Lung Cancer 100%
• Distant Metastasis 66%
• Overall Survival 33%
• Polyethylene Terephthalate 33%
• Recurrent Disease 16%
• Cancer Staging 16%
• Disease Free Survival 16%

Veterinary Science and Veterinary Medicine

• Non-Small Cell Lung Cancer 100%
• Cancer Stages 16%